Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Chlorambucil in Chronic Lymphocytic Leukemia: Mechanism of Action

1 Jan 1996

Abstract excerpt

Chronic lymphocytic leukemia (CLL) is the most common leukemia in Western countries but the clinical presentation and rate of disease progression are highly variable. When treatment is required the most commonly used therapy is the nitrogen mustard alkylating agent, chlorambucil (CLB), with or without prednisone. Although CLB has been used in the treatment of CLL for forty years the exact mechanism of action of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related Molecular Pathways
Share to Chronic Lymphocytic Leukemia Research
Share to Chronic Myeloid Leukemia Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 9031099
DOI: 10.3109/10428199609054821

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Chlorambucil in Chronic Lymphocytic Leukemia: Mechanism of ActionPMID 9031099Read ↗

Chlorambucil drug resistance in chronic lymphocytic leukemia: the emerging role of DNA repair.Semantic proximity Read ↗

P53, MDM-2, BAX and BCL-2 and Drug Resistance in Chronic Lymphocytic LeukemiaSemantic proximity Read ↗

Xanthohumol kills B-chronic lymphocytic leukemia cells by an apoptotic mechanismSemantic proximity Read ↗

Targeting p53-deficient chronic lymphocytic leukemia cells in vitro and in vivo by ROS-mediated mechanism.Semantic proximity Read ↗

Mdm2 inhibitor Nutlin-3a induces p53-mediated apoptosis by transcription-dependent and transcription-independent mechanisms and may overcome Atm-mediated resistance to fludarabine in chronic lymphocytic leukemia.Semantic proximity Read ↗

Mechanism of action of purine analogues in chronic lymphocytic leukaemiaSemantic proximity Read ↗

Expression of Apoptosis-Regulating Proteins in Chronic Lymphocytic Leukemia: Correlations With In Vitro and In Vivo ChemoresponsesSemantic proximity Read ↗

Expression of Apoptosis-Regulating Proteins in Chronic Lymphocytic Leukemia: Correlations With In Vitro and In Vivo ChemoresponsesSemantic proximity Read ↗

Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance.Semantic proximity Read ↗

Studies of glucocorticord resistance in chronic lymphocytic leukaemiaSemantic proximity Read ↗

From pathogenesis to treatment of chronic lymphocytic leukaemiaSemantic proximity Read ↗

Treatment of Chronic Lymphocytic Leukemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.